Webb13 juli 2024 · FLORHAM PARK, N.J., July 13, 2024 -- Phathom Pharmaceuticals, Inc. , a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for... December 3, 2024 Webb11 maj 2024 · Todd Branning 1-877-742-8466 [email protected] PHATHOM PHARMACEUTICALS, INC. Balance Sheets (Unaudited) (in thousands, except share and par value amounts) PHATHOM PHARMACEUTICALS, INC. Statements of Operations and Comprehensive Loss (Unaudited) (in thousands, except share and per share amounts)
PHATHOM PHARMACEUTICALS, INC. : Change in Directors or …
Webb13 juli 2024 · FLORHAM PARK, N.J., July 13, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today announced that it has appointed Todd Branning as Chief Financial Officer. WebbPhathom Pharmaceuticals, Inc. 100 Campus Drive, Suite 102 . Florham Park, New Jersey 07932 . November 13, 2024 . VIA EDGAR . U.S. Securities and Exchange Commission . … rothwork
Phathom Pharmaceuticals to Host Virtual Investor Day
Webb10 jan. 2024 · Branning has more than 25 years of experience leading corporate finance and accounting, tax, financial planning and analysis, and investor relations for several … Webb19 nov. 2024 · Event to be webcast on Monday, December 14, 2024 at 1:00 PM (ET) FLORHAM PARK, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today … Webb13 juli 2024 · Mr. Branning was most recently with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) where he served as Senior Vice President and Chief Financial Officer. rothwood umpires